Ignite Creation Date:
2024-05-06 @ 9:34 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03013543
Status:
COMPLETED
Last Update Posted:
2023-08-18
First Post:
2017-01-03
Brief Title:
Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity
Sponsor:
Rhythm Pharmaceuticals Inc
Organization:
Rhythm Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-03
First Submit QC Date:
January 4 2017
Study First Post Date:
2017-01-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-08-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-25
Last Update Post Date:
2023-08-18
Last Update Post Date Type:
ACTUAL